US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

300.70

+4.391.48%

Pre-market: 293.53-7.1700-2.38%05:42 EDT

Volume:214.27K

Turnover:63.36M

Market Cap:578.69M

PE:- -

High:301.50

Open:291.05

Low:289.32

Close:296.31

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:0.59

T/O Rate:11.13%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Trump: Nominates Dr. Heidi Overton as Next FDA Commissioner

Trump's Truth Social latest posts

Worldwide Healthcare Trust Boosts Treasury Stock in Share Buyback

Why Ryman Healthcare (NZSE:RYM) Is Back In The Spotlight

Simply Wall St.

Alkane Resources Stock Leads These Financially Fit Penny Stocks

Simply Wall St.

Femasys announces FDA approval of FemBloc modular premarket approval application

Teva Pharmaceuticals Says FDA Accepts Ecopipam Filing for Tourette Syndrome

MT Newswires Live

U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome

Press Release: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX) and Irhythm Technologies (IRTC)

Ping An Healthcare And Technology (SEHK:1833) Stock Sinks As Profitability Improves

Simply Wall St.

EPF Boosts Substantial Stake in IHH Healthcare

Galaxy General Achieves Large-Scale Commercial Deployment in Tourism, Manufacturing, and Healthcare Sectors

Guangdong Kanghua Healthcare Schedules Board Meeting on Interim Results and Dividend

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/LABU/news?page=21"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":300.7,"timestamp":1788292800000,"preClose":296.31,"halted":0,"volume":214265,"hourTrading":{"tag":"盘前","latestPrice":293.53,"preClose":300.7,"latestTime":"05:42 EDT","volume":1474,"amount":439217.86215999996,"timestamp":1788342178051,"change":-7.17,"changeRate":-0.023844,"amplitude":0.039741},"delay":0,"changeRate":0.014815564780128873,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Pre-Mkt","change":4.39,"latestTime":"09-02 05:53:30 EDT","open":291.05,"high":301.5,"low":289.32,"amount":63362413.66025,"amplitude":0.041106,"askPrice":304.38,"askSize":1,"bidPrice":290.8,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":300.7,"sharesOutstanding":3074486,"nav":296.788,"aum":571163817.07,"dividendRate":0.003351,"bidAskSpread":0.00268,"preHourTrading":{"tag":"盘前","latestPrice":293.53,"preClose":300.7,"latestTime":"05:42 EDT","volume":1474,"amount":439217.86215999996,"timestamp":1788342178051,"change":-7.17,"changeRate":-0.023844,"amplitude":0.039741},"postHourTrading":{"tag":"盘后","latestPrice":302.3,"preClose":300.7,"latestTime":"19:59 EDT","volume":2272,"amount":684736.992,"timestamp":1788307173491,"change":1.6,"changeRate":0.005321,"amplitude":0.005321},"volumeRatio":0.5944580944086166,"impliedVol":0.9266,"impliedVolPercentile":0.5817},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5944580944086166,"shares":1924486,"dividePrice":1.0075,"high":301.5,"amplitude":0.041106,"preClose":296.31,"low":289.32,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":300.7,"committee":0.99005,"eps":0,"divideRate":0.003351,"volume":214265,"delay":0,"ttmEps":0,"open":291.05,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":335.54,"twentyDayClose":249.47,"sixtyDayClose":160.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:21,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660142283","title":"Trump: Nominates Dr. Heidi Overton as Next FDA Commissioner","url":"https://stock-news.laohu8.com/highlight/detail?id=2660142283","media":"Trump's Truth Social latest posts","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660142283?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:12","pubTimestamp":1787155953,"startTime":"0","endTime":"0","summary":"President Donald Trump on August 19 announced the nomination of Dr. Heidi Overton, MD, PhD, as the next commissioner of the U.S. Food and Drug Administration. In a post on X, Trump praised Overton as...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"724a78f70d7146f1ab07ec048eae1639","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://trumpstruth.org/statuses/41013","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660424236","title":"Worldwide Healthcare Trust Boosts Treasury Stock in Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2660424236","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660424236?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:02","pubTimestamp":1787155357,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) just unveiled an update. Worldwide Healthcare Trust PLC has executed a market purchase of 1,052,58...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-in-share-buyback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-in-share-buyback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4137","LU0029874061.USD","BK4581","BK4588","XLV","LABU","XBI","HCSG","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660424022","title":"Why Ryman Healthcare (NZSE:RYM) Is Back In The Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2660424022","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660424022?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:31","pubTimestamp":1787146306,"startTime":"0","endTime":"0","summary":"Ryman Healthcare (NZSE:RYM) is back in focus after director James Miller signalled his intention to step down to prioritise his new role as Chair of the Financial Markets Authority.\nSee our latest analysis for Ryman Healthcare.\nThe recent reshuffle on Ryman Healthcare’s board comes at a time when the share price is around NZ$2.10, with short term share price returns mixed and longer term total shareholder returns still showing a pronounced decline over three and five years. This pattern...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/why-ryman-healthcare-nzserym-is-back-in-the-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/why-ryman-healthcare-nzserym-is-back-in-the-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK8050","RYM","XLV","BK4585","XBI","BK4152","RYM.NZ","LABU","BK4588","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429545","title":"Alkane Resources Stock Leads These Financially Fit Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429545","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660429545?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:30","pubTimestamp":1787146240,"startTime":"0","endTime":"0","summary":"US housing data now shows a clear strain from tighter mortgage finance. That pressure can keep many buyers on the sidelines and may push more attention toward the stock market, including Financially Fit Penny Stocks. These are lower priced companies filtered for healthier balance sheets. This article examines three stocks from the screener that some investors use to stay engaged in equities without stretching their budgets.\nThe stocks highlighted below are just a small sample from this...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-leads-these-financially-fit-penny-sto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-leads-these-financially-fit-penny-sto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XME","BK4535","BK7067","BK4581","BK7501","ALK.AU","XBI","BK7508","SPHQ","XLV","BK7103","BK7104","SIG.AU","MSB.AU","LABU","BK7506","BK4585","UYM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660252964","title":"Femasys announces FDA approval of FemBloc modular premarket approval application","url":"https://stock-news.laohu8.com/highlight/detail?id=2660252964","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660252964?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:16","pubTimestamp":1787145413,"startTime":"0","endTime":"0","summary":"Femasys (FEMY) announced that the FDA has approved the company’s modular premarket approval application pathway for FemBloc, its investigational no...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-announces-fda-approval-of-fembloc-modular-premarket-approval-application-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLVX","MRNX","BMED","NVIB","IYH","LABU","BBP","BK4082","TBXU","RSPH","SYNB","BK4584","GNMX","GDOC","PSCH","MEDI","FEMY","FRTY","PINK","IBB","MRNY","IDNA","BK4585","BK4539","LFSC","BK4588","IEIH","TECB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660624425","title":"Teva Pharmaceuticals Says FDA Accepts Ecopipam Filing for Tourette Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2660624425","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660624425?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:10","pubTimestamp":1787145009,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries'  US affiliate Teva Pharmaceuticals said Wednesday the US Food and Drug Administration has accepted its new drug application for ecopipam to potentially treat children with Tourette syndrome.The regulator has set a target action date for late in Q1 of 2027, the company said.The application is supported by phase 2b and phase 3 data, which showed a reduction in tic severity and sustained efficacy, Teva said.Teva Pharmaceutical Industries shares were up 1.8% in premarket activity Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4596","BK4584","BK4557","BK4585","BK4588","LU2324357040.USD","BK4566","LABU","TEVA","LU1983299246.USD","BK4559"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660421466","title":"U.S. FDA Accepts Teva’s New Drug Application (NDA) and Grants Priority Review for Ecopipam, a First-in-Class Investigational Therapy for Pediatric Patients with Tourette Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2660421466","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660421466?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:30","pubTimestamp":1787142600,"startTime":"0","endTime":"0","summary":"Ecopipam(EBS-101) is a first-in-class selective D1 (dopamine) receptor antagonist with Orphan Drug designationNDA acceptance is supported by positive Phase 3 data, which were published in JAMA Neurolo","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/19/3347619/0/en/u-s-fda-accepts-teva-s-new-drug-application-nda-and-grants-priority-review-for-ecopipam-a-first-in-class-investigational-therapy-for-pediatric-patients-with-tourette-syndrome.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4157","LABU","AIMS","BK4585","LU0566484027.USD","ECG","BK4129","LU1559883803.SGD","BMI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660238684","title":"Press Release: Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2660238684","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660238684?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:30","pubTimestamp":1787142600,"startTime":"0","endTime":"0","summary":"-- Gross profit of $2,049,994, up 64% year-over-year from $1,246,859.-- Gross profit margin of 48.63%, up from 40.85% - an improvement of 778. -- Reader installed base of 1,886 units as of June 30, 2026, up 22% from","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EES","LABU","BK4082","BK4588","BK4585","INBS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660440196","title":"Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX) and Irhythm Technologies (IRTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660440196","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660440196?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:40","pubTimestamp":1787139607,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Quest Diagnostics (DGX) and Irhythm Technologies (IR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-and-irhythm-technologies-irtc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-and-irhythm-technologies-irtc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2506951958.HKD","XLV","BK4585","BK4137","LABU","LU0950375773.USD","BK4567","LU1854104046.USD","HCSG","LU0029874061.USD","BK4196","DGX","BK4563","LU2506952097.USD","LU1854103824.USD","BK4581","LU0128526141.USD","LU0823417737.USD","LU2506952170.USD","IRTC","XBI","BK4082","LU0823417653.USD","LU2506951875.HKD","BK4588","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660440258","title":"Ping An Healthcare And Technology (SEHK:1833) Stock Sinks As Profitability Improves","url":"https://stock-news.laohu8.com/highlight/detail?id=2660440258","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660440258?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:26","pubTimestamp":1787138777,"startTime":"0","endTime":"0","summary":"Ping An Healthcare and Technology has been treated like a high growth digital health platform with a valuation to match, yet the stock closed at HK$7.13 on 19 August, with the past three months delivering a decline of about 23%. Against that weaker share price, the H1 2026 headline is simple: the company stayed solidly profitable with basic earnings per share of ¥0.10 and net income of ¥219.3 million, while trailing net profit margin held at 8.5%. The market reaction and the income statement...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/ping-an-healthcare-and-technology-sehk1833-stock-sinks-as-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/ping-an-healthcare-and-technology-sehk1833-stock-sinks-as-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HCSG","BK1515","BK1219","BK1142","BK4588","XLV","01833","BK1247","BK1571","BK4581","XBI","LABU","BK1617","BK4585","LU0029874061.USD","BK1615","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660447396","title":"EPF Boosts Substantial Stake in IHH Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447396","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447396?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:52","pubTimestamp":1787136723,"startTime":"0","endTime":"0","summary":"IHH Healthcare Bhd ( ($IHHHF) ) has shared an update. Malaysia’s Employees Provident Fund Board has increased its stake in IHH Healthcare Berhad th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-boosts-substantial-stake-in-ihh-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-boosts-substantial-stake-in-ihh-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","XBI","BK4585","LU0029874061.USD","BK4581","BK4137","LU0128526141.USD","HCSG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164283796","title":"Galaxy General Achieves Large-Scale Commercial Deployment in Tourism, Manufacturing, and Healthcare Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1164283796","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164283796?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:21","pubTimestamp":1787131268,"startTime":"0","endTime":"0","summary":"At the 2026 World Robot Conference (WRC), held from August 19-23 at the Beijing Yichuang International Convention and Exhibition Center, Galaxy General Senior Vice President Zeng Hui shared insights...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159760","BK4581","IJK","XLV","BK4588","BK4585","XBI","BK4550","VHT","VOE","IXJ","REGL","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660445442","title":"Guangdong Kanghua Healthcare Schedules Board Meeting on Interim Results and Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2660445442","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660445442?lang=en_us&edition=fundamental","pubTime":"2026-08-19 16:39","pubTimestamp":1787128742,"startTime":"0","endTime":"0","summary":"The latest update is out from Guangdong Kanghua Healthcare Co., Ltd. Class H ( ($HK:3689) ). Guangdong Kanghua Healthcare Group has scheduled a boa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/guangdong-kanghua-healthcare-schedules-board-meeting-on-interim-results-and-dividend?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/guangdong-kanghua-healthcare-schedules-board-meeting-on-interim-results-and-dividend?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","BK4581","BK4588","BK4137","LU0029874061.USD","XBI","LU0128526141.USD","XLV","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":21,"totalSize":413,"code":"91000000","status":"200"}]}}